Brief: Longevity Health Holdings Announces Execution Of Merger Agreement With 20/20 Biolabs
14/04/2025 15:10
April 14 (Reuters) - Longevity Health Holdings Inc XAGE.O: LONGEVITY HEALTH HOLDINGS ANNOUNCES EXECUTION OF MERGER AGREEMENT WITH 20/20 BIOLABS LONGEVITY HEALTH HOLDINGS INC - COMBINED COMPANY TO TRADE ON NASDAQ UNDER SYMBOL 'XAGE' LONGEVITY HEALTH HOLDINGS INC - POST-CLOSING EQUITY VALUATION OF COMBINED CO EXPECTED TO BE $99 MILLION LONGEVITY HEALTH HOLDINGS INC - MERGER EXPECTED TO DOUBLE LONGEVITY'S FY 2025 REVENUE TO $7-8 MILLION LONGEVITY HEALTH HOLDINGS INC - RAJIV SHUKLA TO REMAIN CHAIRMAN, JONATHAN COHEN TO BE APPOINTED CEO LONGEVITY HEALTH HOLDINGS INC - MERGER EXPECTED TO CLOSE IN Q3 2025 LONGEVITY HEALTH HOLDINGS INC - 20/20 PRE-MERGER STOCKHOLDERS TO OWN 50.1% OF COMBINED COMPANY POST-MERGER Source text: ID:nGNXccSBlb Further company coverage: XAGE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Longevity Health Holdings
See all newsBrief: Longevity Health Holdings Closes Strategic Investment And Appoints Ram Ajjarapu As Chairman And CEO To Drive Acquisition-Focused Growth
Brief: Longevity Health Holdings Says Merger Agreement To Terminate On July 8, If Not Extended - SEC Filing
Brief: Longevity Health Extends Partnership With Humana Through 2030
Brief: Longevity Health Holdings Announces Reverse Stock Split
Brief: Longevity Health Holdings Announces Execution Of Merger Agreement With 20/20 Biolabs